Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Publication of New Study Finding that Lipitor May Raise Risk of Developing Cataracts
Bernstein Liebhard LLP is investigating Lipitor diabetes lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to Lipitor
New York, New York (PRWEB) October 04, 2013
As Lipitor lawsuit claims (http://www.thelipitorlawsuit.com/) involving allegations that the popular statin drug causes Type 2 diabetes continue to move forward in courts around the country, Bernstein Liebhard LLP notes that a newly-published study has found that statins like Lipitor may increase the risk that a person will develop cataracts. The research, which appeared in JAMA Ophthalmology on September 19th, reported that patients who used Lipitor and other statins were 27 percent more likely to develop the eye condition compared to those who did not use the cholesterol-lowering drugs. The study also found that the risk of developing cataracts increased with the length of time a person took the medication.*
“Our Firm has received a number of inquiries from patients who allegedly developed Lipitor diabetes and other side effects. This study serves as a reminder that the use of Lipitor may be associated with a number of serious health consequences,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have been harmed by this medication.
Court records indicate that a number of Lipitor lawsuits have been filed in courts around the country on behalf of individuals who developed Type 2 diabetes following treatment with the statin. In August, the U.S. Judicial Panel on Multidistrict Litigation (JPML) rejected a request by plaintiffs to consolidate all Lipitor diabetes lawsuits in a single federal court for pretrial proceedings. However, individuals who believe they may have developed diabetes due to their use of Lipitor can still pursue product liability claims against the manufacturer of this drug. In fact, the JPML noted that a judge in U.S. District Court, District of South Carolina, is informally handling Lipitor diabetes lawsuits in a consolidated manner, and that Pfizer, Inc. has agreed to cooperate with that process. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)
Lipitor diabetes claims have been mounting since January 2012, after a study published in JAMA: Internal Medicine reported that post-menopausal women treated with the statin may be at an increased risk for developing the disease.** The following month, the U.S. Food & Drug Administration (FDA) mandated that Pfizer add new warnings to Lipitor label regarding this potential risk.
In May 2013, another study published in the British Medical Journal appeared to confirm the association between Lipitor and diabetes, and reported that patients treated with the medication had a 22 percent higher risk of new-onset diabetes.***
Alleged victims of Lipitor diabetes may be entitled to compensation for medical bills, lost wages, and pain and suffering. Learn More about the side effects that may be associated with Lipitor at Bernstein Liebhard LLP's website. To arrange for a free case review, please call 800-511-5092.
*archopht.jamanetwork.com/article.aspx?articleid=1739520&resultClick=3, Ophthalmology, September 19, 2013
**archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
***bmj.com/content/346/bmj.f2610, BMJ, May 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs' Hot List,” recognizing the top plaintiffs' firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11198607.htm